References
- Ambudkar , SV , Dey , S , Hrycyna , CA , Ramachandra , M , Pastan , I and Gottesman , MM . 1999 . Biochemical, cellular, and pharmacological aspects of the multidrug transporter . Annual Review of Pharmacology and Toxicology , 39 : 361 – 398 .
- Deeley , RG and Cole , SP . 1997 . Function, evolution and structure of multidrug resistance protein (MRP) . Seminars in Cancer Biology , 8 : 193 – 204 .
- Fardel , O , Lecureur , V and Guillouzo , A . 1996 . The P-glycoprotein multidrug transporter . General Pharmacology , 27 : 1283 – 1291 .
- Fu , YL and Chen , T . 2008 . Research of traditional Chinese medicine in the treatment of leukemia: current status . Journal of Chinese Integrative Medicine , 6 : 867 – 872 .
- Gottesman , MM . 2002 . Mechanisms of cancer drug resistance . Annual Review of Medicine , 53 : 615 – 627 .
- Kerb , R , Hoffmeyer , S and Brinkmann , U . 2001 . ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2 . Pharmacogenomics , 2 : 51 – 64 .
- Ling , V . 1997 . Multidrug resistance: molecular mechanisms and clinical relevance . Cancer Chemotherapy and Pharmacology , 40 : S3 – S8 .
- Lu , P , Liu , R and Sharom , FJ . 2001 . Drug transport by reconstituted P-glycoprotein in proteoliposomes – effect of substrates and modulators, and dependence on bilayer phase state . European Journal of Biochemistry , 268 : 1687 – 1697 .
- Romsicki , Y and Sharom , FJ . 1999 . The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter . Biochemistry , 38 : 6887 – 6896 .
- Ross , DD , Yang , W , Abruzzo , LV , Dalton , WS , Schneider , E , Lage , H Doyle , LA . 1999 . A typical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines . Journal of the National Cancer Institute , 91 : 429 – 433 .
- Sarkadi , B and Muller , M . 1997 . Search for specific inhibitors of multidrug resistance in cancer . Seminars in Cancer Biology , 8 : 171 – 182 .
- Scheper , RJ , Broxterman , HJ , Scheffer , GL , Kaaijk , P , Dalton , WS , van Heijningen , TH Herbert , MP . 1993 . Overexpression of a Mr 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance . Cancer Research , 53 : 1475 – 1479 .
- Zhang , Y , Li , H , Wang , H , Su , F , Qu , R , Yin , D Chen , XG . 2010 . Syl611, a novel semisynthetic taxane derivative, reverses multidrug resistance by p-glycoprotein inhibition and facilitating inward transmembrane action . Cancer Chemotherapy and Pharmacology , 66 : 851 – 859 .